Books and Trials
Recent Trials in Cardiology
Volume 2, Oct 2013
Vineet Bhatia MD, DM, Parneesh Arora MD, DM, Meetu Arora, MD, PGDCC, Nishith Chandra, MD, DM, New Delhi, India
Anticoagulation for 3 weeks before and 4 weeks postcardioversion for patients with atrial fibrillation (AF) has been the standard of care. AF of <48 hours (acute AF) duration has been traditionally cardioverted without anticoagulation cover. However, as the risk of embolization in this latter setting is real, recent guidelines recommend anticoagulation therapy during and after cardioversion in patients with acute AF and risk factors for stroke. The FinCV (Finnish CardioVersion) study was undertaken to answer these questions regarding anticoagulation in Acute AF.
Volume 2, Number 4, Pages: 214-5
Full text of this article:
HTML
|
PDF
Print: ISSN: 2250-3528